<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1453">
 <bold>Methods:</bold> From 2008 to 2012 admitted to our ICU 384 patients. We looked for the percentage of ventilated patients developed VAP as well as the use of the following agents as items per ventilation day per ventilated patient: Imipenem / cilastatin (vial 500 + 500 mg), Meropenem (vial 1000 mg), Tigecyclin (vial 50 mg), Linezoline (bag, 2 mg / ml x 300 ml), Colistin IV (vial 106 IU). Using linear correlation, we looked for linear slope, correlation coefficient (r), coefficient of determination (r2), r and p value.
</p>
